$CNS
COHEN & STEERS, INC.

2020 Q3 Form 10-Q Financial Statement

#000128481220000169 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $111.2M $105.0M $101.8M
YoY Change 5.9% 6.75% 7.82%
Cost Of Revenue $14.60M $14.10M $14.20M
YoY Change 3.55% 6.82% 14.52%
Gross Profit $96.50M $90.80M $87.60M
YoY Change 6.28% 6.7% 6.83%
Gross Profit Margin 86.81% 86.51% 86.06%
Selling, General & Admin $52.10M $49.60M $48.40M
YoY Change 5.04% 10.71% 8.76%
% of Gross Profit 53.99% 54.63% 55.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.144M $1.100M $1.100M
YoY Change 4.0% -3.34% -8.33%
% of Gross Profit 1.19% 1.21% 1.26%
Operating Expenses $67.85M $64.83M $63.69M
YoY Change 4.66% 9.68% 9.57%
Operating Profit $43.31M $40.13M $38.10M
YoY Change 7.91% 2.32% 5.01%
Interest Expense $4.000M $6.200M $3.800M
YoY Change -35.48% 93.75% 65.22%
% of Operating Profit 9.24% 15.45% 9.97%
Other Income/Expense, Net $3.231M $6.617M $4.536M
YoY Change -51.17% 532.0% -683.03%
Pretax Income $46.54M $46.75M $42.64M
YoY Change -0.45% 16.09% 20.08%
Income Tax $12.53M $10.35M $9.991M
% Of Pretax Income 26.93% 22.14% 23.43%
Net Earnings $31.90M $34.02M $31.33M
YoY Change -6.21% 10.48% 4.59%
Net Earnings / Revenue 28.7% 32.41% 30.78%
Basic Earnings Per Share $0.67 $0.72 $0.66
Diluted Earnings Per Share $0.66 $0.70 $0.65
COMMON SHARES
Basic Shares Outstanding 47.86M shares 47.32M shares 47.30M shares
Diluted Shares Outstanding 48.68M shares 48.41M shares 48.18M shares

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.30M $128.3M $102.1M
YoY Change -24.94% -22.01% -47.29%
Cash & Equivalents $96.31M $128.3M $102.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $67.10M $65.60M $54.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $163.4M $193.9M $156.5M
YoY Change -15.73% -13.67% -35.94%
LONG-TERM ASSETS
Property, Plant & Equipment $10.92M $12.99M $13.49M
YoY Change -15.95% -8.47% -7.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $15.00K $491.0K $24.00K
YoY Change -96.95% 1653.57% -99.98%
Other Assets $7.100M $7.100M $7.200M
YoY Change 0.0% 5.97% 89.47%
Total Long-Term Assets $234.1M $265.8M $247.5M
YoY Change -11.94% 0.84% 20.25%
TOTAL ASSETS
Total Short-Term Assets $163.4M $193.9M $156.5M
Total Long-Term Assets $234.1M $265.8M $247.5M
Total Assets $397.5M $459.7M $404.0M
YoY Change -13.54% -5.83% -10.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $1.600M $2.400M
YoY Change -81.25% -57.89% -56.36%
Accrued Expenses $74.30M $83.40M $72.40M
YoY Change -10.91% 163.09% 249.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $104.8M $113.7M $100.2M
YoY Change -7.83% 80.48% 113.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.60M $14.00M $9.300M
YoY Change -17.14% -13.58% -38.82%
Total Long-Term Liabilities $11.60M $14.00M $9.300M
YoY Change -17.14% -13.58% -38.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $104.8M $113.7M $100.2M
Total Long-Term Liabilities $11.60M $14.00M $9.300M
Total Liabilities $116.3M $127.7M $109.5M
YoY Change -8.93% 61.4% 76.32%
SHAREHOLDERS EQUITY
Retained Earnings -$218.6M -$163.5M -$179.9M
YoY Change 33.73% 69.35% 61.54%
Common Stock $535.0K $527.0K $526.0K
YoY Change 1.52% 1.74% 1.54%
Preferred Stock
YoY Change
Treasury Stock (at cost) $200.8M $174.8M $174.8M
YoY Change 14.84% 6.33% 6.35%
Treasury Stock Shares 5.675M shares 5.329M shares 5.329M shares
Shareholders Equity $235.8M $278.9M $256.4M
YoY Change
Total Liabilities & Shareholders Equity $397.5M $459.7M $404.0M
YoY Change -13.54% -5.83% -10.24%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income $31.90M $34.02M $31.33M
YoY Change -6.21% 10.48% 4.59%
Depreciation, Depletion And Amortization $1.144M $1.100M $1.100M
YoY Change 4.0% -3.34% -8.33%
Cash From Operating Activities $31.60M $27.90M $75.40M
YoY Change 13.26% -15.96% 114.2%
INVESTING ACTIVITIES
Capital Expenditures -$400.0K -$600.0K -$600.0K
YoY Change -33.33% -14.29% -33.33%
Acquisitions
YoY Change
Other Investing Activities -$5.700M -$2.600M $15.60M
YoY Change 119.23% -94.48% -2700.0%
Cash From Investing Activities -$6.100M -$3.200M $15.00M
YoY Change 90.63% -93.31% -1100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.20M 2.900M -44.40M
YoY Change -727.59% -120.0% 492.0%
NET CHANGE
Cash From Operating Activities 31.60M 27.90M 75.40M
Cash From Investing Activities -6.100M -3.200M 15.00M
Cash From Financing Activities -18.20M 2.900M -44.40M
Net Change In Cash 7.300M 27.60M 46.00M
YoY Change -73.55% -194.85% 75.57%
FREE CASH FLOW
Cash From Operating Activities $31.60M $27.90M $75.40M
Capital Expenditures -$400.0K -$600.0K -$600.0K
Free Cash Flow $32.00M $28.50M $76.00M
YoY Change 12.28% -15.93% 110.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001284812
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32236
dei Entity Registrant Name
EntityRegistrantName
COHEN & STEERS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
14-1904657
dei Entity Address Address Line1
EntityAddressAddressLine1
280 Park Avenue,
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
832-3232
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
CNS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47785725 shares
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96305000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101352000 USD
CY2020Q3 us-gaap Investments
Investments
151365000 USD
CY2019Q4 us-gaap Investments
Investments
155213000 USD
CY2020Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
67094000 USD
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
59101000 USD
CY2020Q3 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
2443000 USD
CY2019Q4 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
1743000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10920000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33649000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38440000 USD
CY2020Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
20023000 USD
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
19560000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7073000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7091000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
8594000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
7433000 USD
CY2020Q3 us-gaap Assets
Assets
397466000 USD
CY2019Q4 us-gaap Assets
Assets
402419000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36615000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48105000 USD
CY2020Q3 cns Distribution And Service Fees Payable
DistributionAndServiceFeesPayable
6722000 USD
CY2019Q4 cns Distribution And Service Fees Payable
DistributionAndServiceFeesPayable
7318000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
22194000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37669000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43349000 USD
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
23440000 USD
CY2020Q3 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
293000 USD
CY2019Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
366000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
11553000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
13972000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
116292000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
135304000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
45420000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
53412000 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53456437 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52580246 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
535000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
527000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
660689000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
636788000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218643000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242461000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6065000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6326000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
5674510 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5329820 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
200762000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
174825000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
235754000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
213703000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
397466000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
402419000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
111159000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
104965000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
311076000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
300983000 USD
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
41060000 USD
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
37877000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
113997000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
108438000 USD
CY2020Q3 us-gaap Sponsor Fees
SponsorFees
14642000 USD
CY2019Q3 us-gaap Sponsor Fees
SponsorFees
14142000 USD
us-gaap Sponsor Fees
SponsorFees
41264000 USD
us-gaap Sponsor Fees
SponsorFees
40866000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11006000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11713000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45320000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34690000 USD
CY2020Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1144000 USD
CY2019Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1100000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
3524000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
3317000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
67852000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
64832000 USD
us-gaap Operating Expenses
OperatingExpenses
204105000 USD
us-gaap Operating Expenses
OperatingExpenses
187311000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
43307000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
40133000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
106971000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
113672000 USD
CY2020Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
694000 USD
CY2019Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1713000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2736000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
5174000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
3279000 USD
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
4472000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-11431000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
20210000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-742000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
432000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
679000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3231000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6617000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8659000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26063000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46538000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46750000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
98312000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
139735000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12532000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10352000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24076000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30711000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
34006000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
36398000 USD
us-gaap Profit Loss
ProfitLoss
74236000 USD
us-gaap Profit Loss
ProfitLoss
109024000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2102000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2381000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6760000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11131000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
31904000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
34017000 USD
us-gaap Net Income Loss
NetIncomeLoss
80996000 USD
us-gaap Net Income Loss
NetIncomeLoss
97893000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.17
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.08
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47855000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47316000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47778000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47256000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48681000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48412000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48588000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48118000 shares
CY2020Q3 us-gaap Profit Loss
ProfitLoss
34006000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
36398000 USD
us-gaap Profit Loss
ProfitLoss
109024000 USD
us-gaap Profit Loss
ProfitLoss
74236000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2102000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2381000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6760000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11131000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
31904000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
34017000 USD
us-gaap Net Income Loss
NetIncomeLoss
80996000 USD
us-gaap Net Income Loss
NetIncomeLoss
97893000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1357000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1900000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
261000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1800000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33261000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32117000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81257000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
96093000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
213543000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2020Q3 us-gaap Dividends
Dividends
19138000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
225000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
22000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
652000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7247000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
14000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
31904000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1357000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
235754000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
256375000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2019Q3 us-gaap Dividends
Dividends
17665000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
185000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
23000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1135000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6784000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
7000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
34017000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1900000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
278901000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
213703000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.17
us-gaap Dividends
Dividends
57178000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
835000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
25937000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1721000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21398000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
45000 USD
us-gaap Net Income Loss
NetIncomeLoss
80996000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
261000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
235754000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
222646000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.08
us-gaap Dividends
Dividends
52989000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
727000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10408000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2718000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20129000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
15000 USD
us-gaap Net Income Loss
NetIncomeLoss
97893000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1800000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
278901000 USD
us-gaap Profit Loss
ProfitLoss
74236000 USD
us-gaap Profit Loss
ProfitLoss
109024000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
22002000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
21019000 USD
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1309000 USD
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
736000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
3524000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
3317000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
4791000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
7655000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
194000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
408000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-11431000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
20210000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
108000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
559000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
40000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7434000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15193000 USD
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
700000 USD
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
945000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1075000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1067000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-545000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
15654000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1194000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3525000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11490000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-6299000 USD
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-596000 USD
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
10000 USD
cns Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-5680000 USD
cns Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-8257000 USD
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-73000 USD
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
1312000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1246000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1491000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2944000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
704000 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
1207000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
87188000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73778000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
58679000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
47742000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
51059000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
70460000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1962000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2197000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9582000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20521000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
710000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
619000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25937000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10408000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
55971000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
51068000 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
5774000 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
35978000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
4542000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
39149000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-82430000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57686000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4824000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36613000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-223000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1018000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101352000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92733000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96305000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
128328000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
25425000 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
2662000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
29446000 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
348000 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
1921000 USD
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">—The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes the estimates used in preparing the condensed consolidated financial statements are reasonable and prudent. Actual results could differ from those estimates due to factors we cannot fully predict including the extent of the impact to the Company's business from the ongoing COVID-19 pandemic. The extent to which the COVID-19 pandemic may continue to impact the Company's business, results of operations, financial condition or liquidity could affect the Company's accounting estimates and will depend on ongoing and future developments which are highly uncertain and cannot be predicted, including the duration and severity of the pandemic, the prospects for a sustained recovery in the financial markets and the length of time it will take for the Company's workforce to fully and safely return to the workplace.</span>
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">—The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes the estimates used in preparing the condensed consolidated financial statements are reasonable and prudent. Actual results could differ from those estimates due to factors we cannot fully predict including the extent of the impact to the Company's business from the ongoing COVID-19 pandemic. The extent to which the COVID-19 pandemic may continue to impact the Company's business, results of operations, financial condition or liquidity could affect the Company's accounting estimates and will depend on ongoing and future developments which are highly uncertain and cannot be predicted, including the duration and severity of the pandemic, the prospects for a sustained recovery in the financial markets and the length of time it will take for the Company's workforce to fully and safely return to the workplace.</span>
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-6065000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-6326000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
111159000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
104965000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
311076000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
300983000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
111159000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
104965000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
311076000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
300983000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
89872000 USD
CY2019Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
14980000 USD
CY2019Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
49807000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
554000 USD
CY2019Q3 us-gaap Investments
Investments
151365000 USD
CY2019Q4 us-gaap Investments
Investments
155213000 USD
CY2020Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
50100000 USD
CY2019Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
50000000.0 USD
cns Number Of New Funds Seeded
NumberOfNewFundsSeeded
1 new_funds_seeded
cns Number Of New Funds Seeded
NumberOfNewFundsSeeded
2 new_funds_seeded
CY2020Q3 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
-177000 USD
CY2019Q3 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1359000 USD
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
-5598000 USD
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
5118000 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
3456000 USD
CY2019Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
3113000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-5833000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
15092000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
3279000 USD
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
4472000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-11431000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
20210000 USD
CY2019Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
83492000 USD
CY2019Q3 us-gaap Trading Securities Debt
TradingSecuritiesDebt
17406000 USD
CY2019Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
49976000 USD
CY2019Q3 us-gaap Equity Method Investments
EquityMethodInvestments
491000 USD
CY2020Q3 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
12675000 USD
CY2020Q3 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
46453000 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
709000 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
616000 USD
us-gaap Profit Loss
ProfitLoss
109024000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2102000 USD
CY2019Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
14394000 USD
CY2019Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
24319000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
644000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
556000 USD
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-255000 USD
CY2019Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
173000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-251000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
532000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
34006000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
36398000 USD
us-gaap Profit Loss
ProfitLoss
74236000 USD
us-gaap Net Income Loss
NetIncomeLoss
97893000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2381000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6760000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11131000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
31904000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
34017000 USD
us-gaap Net Income Loss
NetIncomeLoss
80996000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47855000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47316000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47778000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47256000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
826000 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1096000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
810000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
862000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48681000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48412000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48588000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48118000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.07
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210

Files In Submission

Name View Source Status
0001284812-20-000169-index-headers.html Edgar Link pending
0001284812-20-000169-index.html Edgar Link pending
0001284812-20-000169.txt Edgar Link pending
0001284812-20-000169-xbrl.zip Edgar Link pending
cns-20200930.htm Edgar Link pending
cns-20200930.xsd Edgar Link pending
cns-20200930_cal.xml Edgar Link unprocessable
cns-20200930_def.xml Edgar Link unprocessable
cns-20200930_g1.jpg Edgar Link pending
cns-20200930_htm.xml Edgar Link completed
cns-20200930_lab.xml Edgar Link unprocessable
cns-20200930_pre.xml Edgar Link unprocessable
cns10q-93020ex311.htm Edgar Link pending
cns10q-93020ex312.htm Edgar Link pending
cns10q-93020ex321.htm Edgar Link pending
cns10q-93020ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending